224 related articles for article (PubMed ID: 18250026)
1. Molecular imaging in oncology.
Dzik-Jurasz AS
Cancer Imaging; 2004 Oct; 4(2):162-73. PubMed ID: 18250026
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging: an overview and clinical applications.
Rollo FD
Radiol Manage; 2003; 25(3):28-32; quiz 33-5. PubMed ID: 12817419
[TBL] [Abstract][Full Text] [Related]
5. Imaging to study solid tumour origin and progression: lessons from research and clinical oncology.
Raimondo S; Zito G
Immunol Cell Biol; 2017 Jul; 95(6):531-537. PubMed ID: 28294139
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of gene and cell therapies.
Allport JR; Weissleder R
Exp Hematol; 2001 Nov; 29(11):1237-46. PubMed ID: 11698119
[TBL] [Abstract][Full Text] [Related]
7. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
8. Imaging and the completion of the omics paradigm in breast cancer.
Leithner D; Horvat JV; Ochoa-Albiztegui RE; Thakur S; Wengert G; Morris EA; Helbich TH; Pinker K
Radiologe; 2018 Nov; 58(Suppl 1):7-13. PubMed ID: 29947931
[TBL] [Abstract][Full Text] [Related]
9. Contribution of oncoproteomics to cancer biomarker discovery.
Cho WC
Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
12. Beware the Medical-Industrial Complex.
Stevens CW; Glatstein E
Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
[TBL] [Abstract][Full Text] [Related]
13. Molecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies.
Gangadaran P; Ahn BC
Front Immunol; 2017; 8():1090. PubMed ID: 28955332
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of cancer risk and therapeutic benefit: new technologies, new opportunities, and some challenges.
MacGregor JT
Toxicol Pathol; 2004; 32 Suppl 1():99-105. PubMed ID: 15209409
[TBL] [Abstract][Full Text] [Related]
15. PET: the merging of biology and imaging into molecular imaging.
Phelps ME
J Nucl Med; 2000 Apr; 41(4):661-81. PubMed ID: 10768568
[TBL] [Abstract][Full Text] [Related]
16. New science-based endpoints to accelerate oncology drug development.
Kelloff GJ; Sigman CC
Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
[TBL] [Abstract][Full Text] [Related]
17. Components of a curriculum for molecular imaging scientists.
Zinn KR; Anderson CJ; Bradbury M; Cutler CS; Peterson TE; Morgan DE; Price JC; Graham MM; Contag CH; Wittstrom K; Norenberg JP
J Nucl Med; 2011 Apr; 52(4):650-6. PubMed ID: 21421709
[TBL] [Abstract][Full Text] [Related]
18. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
19. Towards inexpensive DNA diagnostics.
Abramowitz S
Trends Biotechnol; 1996 Oct; 14(10):397-401. PubMed ID: 8987638
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
